Home  /  Resource Library  /  Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA conclusions from the evaluation of 38 suspected cases

Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA conclusions from the evaluation of 38 suspected cases

Study investigated secondary cancers following CAR-T therapy.